Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions
October 01 2024 - 8:00AM
Stryker (NYSE: SYK) announced today that it has completed the
acquisition of Vertos Medical Inc., a leader in interventional pain
management solutions for chronic lower back pain caused by lumbar
spinal stenosis.
“The acquisition of Vertos Medical enhances our unique,
non-surgical solutions for interventionalists addressing chronic
lower back pain, while broadening our presence in ambulatory
surgery centers," said Andy Pierce, Group President, MedSurg and
Neurotechnology, Stryker. “We look forward to enabling physicians
with the minimally invasive mild® procedure so patients can reclaim
their quality of life.”
The addition of Vertos Medical’s differentiated portfolio will
strengthen Stryker’s impact in interventional solutions to address
chronic pain.
About StrykerStryker is a global leader in
medical technologies and, together with its customers, is driven to
make healthcare better. The company offers innovative products and
services in MedSurg, Neurotechnology, Orthopaedics and Spine that
help improve patient and healthcare outcomes. Alongside its
customers around the world, Stryker impacts more than 150 million
patients annually. More information is available at
www.stryker.com.
Media contactBeth SizemoreSr. Director,
Strategic Communicationsbeth.sizemore@stryker.com
Stryker (NYSE:SYK)
Historical Stock Chart
From Nov 2024 to Dec 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Dec 2023 to Dec 2024